Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002282-30Phase 4Completed
Phase 4, single-arm trial of atorvastatin in myocardial ischemia-reperfusion injury, sponsored by Region Östergötland. Primary endpoint: Plasma biomarkers of matrix remodeling, apoptosis, inflammation, and oxidative stress. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002282-30.